Author:
Doyle Hester A.,Koski Raymond A.,Bonafé Nathalie,Bruck Ross A.,Tagliatela Stephanie M.,Gee Renelle J.,Mamula Mark J.
Funder
National Institutes of Health
M.J. and Caral G. Lebworth Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference45 articles.
1. Fischer-Colbrie J, Witt A, Heinzl H, Speiser P, Czerwenka K, Sevelda P, Zeillinger R (1997) EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Res 17:613–619
2. Magne N, Pivot X, Bensadoun RJ et al (2001) The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy. Eur J Cancer 37:2169–2177
3. Beji A, Horst D, Engel J, Kirchner T, Ullrich A (2012) Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancer. Clin Cancer Res 18:956–968.
https://doi.org/10.1158/1078-0432.CCR-11-1186
4. Milella M, Nuzzo C, Bria E et al (2012) EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. J Thorac Oncol 7:672–680.
https://doi.org/10.1097/JTO.0b013e31824a8bde
5. da Cunha Santos G, Shepherd FA, Tsao MS (2011) EGFR mutations and lung cancer. Annu Rev Pathol 6:49–69.
https://doi.org/10.1146/annurev-pathol-011110-130206
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献